Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
ADVX
Agreement with Knight Therapeutics, Knight is purchasing directly from Advaxis 359,454 shares at $13.91 per share. In addition, Sectoral Asset Management, a leading Canadian-based global healthcare investment advisor, is purchasing 1,437,815 shares at $13.91 per share directly from Advaxis on behalf of its clients. The combined gross proceeds to Advaxis from these direct investments is $25 million.
Under the terms of the licensing agreement, Knight will be responsible for all commercial activities related to Advaxis current and future products, including axalimogene filolisbac, ADXS-PSA and ADXS-HER2, in Canada. Advaxis is eligible to receive double digit royalty as well as sales milestones.
"We believe Advaxis's technology has significant potential to treat a multitude of cancers,"
Y esto es de hace 2 semanas, que nadie lo posteó.
2 becas de 1 millón cada una del Movember Foundation-PCF Challenge Awards awarded to two ADXS-PSA teams conducting innovative large-scale research projects concerning metastatic, treatment-resistant prostate cancer, an advanced form of the disease with often-lethal outcomes.
En total, este mes ADXS se ha sacado 27 kilos de la nada.
Re: Farmas USA
91,60 la pusiste para GILD, no??
Por debajo de 95 entro yo fijo, luego ya veria a ver como afino.